Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pivotal 1 Study of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04704921
Recruitment Status : Recruiting
First Posted : January 12, 2021
Last Update Posted : May 6, 2021
Sponsor:
Information provided by (Responsible Party):
Regenxbio Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : March 2024